UK Medtech Market Access: More About Mindset Than The Money
The journey from medtech concept to implementation is long and slow, and new ideas often don’t make it all the way to manufacturing and approval. But when they do, what is needed is a system that guarantees adoption and usage of those proven, innovative solutions that clear the many hurdles en route to clinical practice.
You may also be interested in...
The current hiatus in the Brexit debate has left room for other themes of clinical and commercial importance to the UK medtech industry to rise back to the surface of the national debate. The potential value of the Long Term Plan and innovation adoption and spread, among others, will share top billing at the ABHI’s 2019 UK Market Conference, in mid-June.
Hopes are high for the NHS Long Term Plan’s ability to transform health-care delivery and make a potentially unsustainable service fit for the future. There are opportunities for diagnostics, devices and digital providers, but are the resources there to turn the Plan into a success story?
The UK's future economic relationship with the EU consumed more than its fair share of headlines in 2018. But within UK health care, at ground level, Brexit was often missing entirely from main conference agendas, as stakeholders sought to both maximize current operating conditions and prepare for future health-care architectures and evolving innovation systems. That was the case at Medtech Futures, in Cambridge, UK, this fall.